These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 29354818)

  • 21. Polymeric micelles for ocular drug delivery: From structural frameworks to recent preclinical studies.
    Mandal A; Bisht R; Rupenthal ID; Mitra AK
    J Control Release; 2017 Feb; 248():96-116. PubMed ID: 28087407
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Silica xerogels as pharmaceutical drug carriers.
    Quintanar-Guerrero D; Ganem-Quintanar A; Nava-Arzaluz MG; Piñón-Segundo E
    Expert Opin Drug Deliv; 2009 May; 6(5):485-98. PubMed ID: 19413456
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Overview on Therapeutic Applications of Microparticulate Drug Delivery Systems.
    Bale S; Khurana A; Reddy AS; Singh M; Godugu C
    Crit Rev Ther Drug Carrier Syst; 2016; 33(4):309-361. PubMed ID: 27910739
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Preparation of Novel Functional Drug Particles Embedded in a Gelling-Swelling Layer (PEGS) for Taste Masking and Subsequent Rapid Drug Release.
    Ijitsu S; Hoashi Y; Hori K; Okimoto K; Kai T; Yoshida M; Uchida T
    Chem Pharm Bull (Tokyo); 2021 Apr; 69(4):383-390. PubMed ID: 33518551
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Drug release from a pH-sensitive multiblock co-polymer thermogel.
    Garripelli VK; Namgung R; Kim WJ; Jo S
    J Biomater Sci Polym Ed; 2012; 23(12):1505-19. PubMed ID: 21771392
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gels without Vapor Pressure: Soft, Nonaqueous, and Solvent-Free Supramolecular Biomaterials for Prospective Parenteral Drug Delivery Applications.
    Tabet A; Wang C
    Adv Healthc Mater; 2019 Mar; 8(6):e1800908. PubMed ID: 30450824
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development of triptolide-nanoemulsion gels for percutaneous administration: physicochemical, transport, pharmacokinetic and pharmacodynamic characteristics.
    Yang M; Gu Y; Yang D; Tang X; Liu J
    J Nanobiotechnology; 2017 Dec; 15(1):88. PubMed ID: 29202753
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Incorporating small molecules or biologics into nanofibers for optimized drug release: A review.
    Sebe I; Szabó P; Kállai-Szabó B; Zelkó R
    Int J Pharm; 2015 Oct; 494(1):516-30. PubMed ID: 26307263
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Development of novel bioadhesive granisetron hydrochloride spanlastic gel and insert for brain targeting and study their effects on rats.
    Abdelmonem R; El Nabarawi M; Attia A
    Drug Deliv; 2018 Nov; 25(1):70-77. PubMed ID: 29228824
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-term delivery of protein therapeutics.
    Vaishya R; Khurana V; Patel S; Mitra AK
    Expert Opin Drug Deliv; 2015 Mar; 12(3):415-40. PubMed ID: 25251334
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular imprinting within hydrogels II: progress and analysis of the field.
    Byrne ME; Salian V
    Int J Pharm; 2008 Dec; 364(2):188-212. PubMed ID: 18824226
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Availability of polymeric nanoparticles for specific enhanced and targeted drug delivery.
    Kiriyama A; Iga K; Shibata N
    Ther Deliv; 2013 Oct; 4(10):1261-78. PubMed ID: 24116911
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of polymers on dissolution performance of an amorphous gelleable drug from surface-coated beads.
    Fan C; Pai-Thakur R; Phuapradit W; Zhang L; Tian H; Malick W; Shah N; Kislalioglu MS
    Eur J Pharm Sci; 2009 Apr; 37(1):1-10. PubMed ID: 19027852
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nanocarriers for oral drug delivery.
    Zhang L; Wang S; Zhang M; Sun J
    J Drug Target; 2013 Jul; 21(6):515-27. PubMed ID: 23621127
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Liposomal drugs dispersed in hydrogels. Effect of liposome, drug and gel properties on drug release kinetics.
    Mourtas S; Fotopoulou S; Duraj S; Sfika V; Tsakiroglou C; Antimisiaris SG
    Colloids Surf B Biointerfaces; 2007 Apr; 55(2):212-21. PubMed ID: 17223020
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Organogels in Drug Delivery: A Special Emphasis on Pluronic Lecithin Organogels.
    Alsaab H; Bonam SP; Bahl D; Chowdhury P; Alexander K; Boddu SH
    J Pharm Pharm Sci; 2016; 19(2):252-73. PubMed ID: 27518174
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nanocarrier systems for oral drug delivery: do we really need them?
    Bernkop-Schnürch A
    Eur J Pharm Sci; 2013 May; 49(2):272-7. PubMed ID: 23537503
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Formulation and evaluation of novel controlled release of topical pluronic lecithin organogel of mefenamic acid.
    Jhawat V; Gupta S; Saini V
    Drug Deliv; 2016 Nov; 23(9):3573-3581. PubMed ID: 27494650
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Heterogeneous polymer composite nanoparticles loaded in situ gel for controlled release intra-vaginal therapy of genital herpes.
    Ramyadevi D; Rajan KS; Vedhahari BN; Ruckmani K; Subramanian N
    Colloids Surf B Biointerfaces; 2016 Oct; 146():260-70. PubMed ID: 27351137
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Classification of stimuli-responsive polymers as anticancer drug delivery systems.
    Taghizadeh B; Taranejoo S; Monemian SA; Salehi Moghaddam Z; Daliri K; Derakhshankhah H; Derakhshani Z
    Drug Deliv; 2015 Feb; 22(2):145-55. PubMed ID: 24547737
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.